enzastaurin has been researched along with Inflammation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becker, S; Bittner, S; Gaikwad, S; Grabitz, C; Iwantscheff, S; Lanz, TV; Litzenburger, UM; Meuth, SG; Mittelbronn, M; Opitz, CA; Osswald, M; Ott, M; Platten, M; Sahm, F; Schuhmann, MK; von Deimling, A; Wick, W; Wiestler, B; Winkler, F | 1 |
Baldwin, J; Bell, RL; Coutant, DE; Hall, SD; Kulanthaivel, P; Pitou, C; Turner, PK; Wijayawardana, SR | 1 |
1 review(s) available for enzastaurin and Inflammation
Article | Year |
---|---|
Understanding Disease-Drug Interactions in Cancer Patients: Implications for Dosing Within the Therapeutic Window.
Topics: Acute-Phase Proteins; Cytochrome P-450 Enzyme System; Cytokines; Drug Interactions; Humans; Imidazoles; Indoles; Inflammation; Meta-Analysis as Topic; Midazolam; Neoplasms; p38 Mitogen-Activated Protein Kinases; Protein Kinase C beta; Pyridines | 2015 |
1 other study(ies) available for enzastaurin and Inflammation
Article | Year |
---|---|
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
Topics: Animals; Blood-Brain Barrier; Cell Proliferation; Claudin-3; Claudin-5; Cytokines; Demyelinating Diseases; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Endothelial Cells; Female; Gene Expression Profiling; Immunohistochemistry; Indoles; Inflammation; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Microscopy, Confocal; Protein Kinase C beta; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes; Tight Junctions; Transendothelial and Transepithelial Migration; Zonula Occludens-1 Protein | 2013 |